ARTICLE | Clinical News
AS703026 regulatory update
October 25, 2010 7:00 AM UTC
The COMP issued a positive opinion to grant Orphan Drug designation for Merck's AS703026 to treat acute myelogenous leukemia (AML). AS703026 is a MEK inhibitor. COMP is part of the European Medicines...